"4-1BB Ligand" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A membrane bound member of the TNF superfamily that is expressed on activated B-LYMPHOCYTES; MACROPHAGES; and DENDRITIC CELLS. The ligand is specific for the 4-1BB RECEPTOR and may play a role in inducing the proliferation of activated peripheral blood T-LYMPHOCYTES.
    
			
			
				
				
					
						| Descriptor ID | D053330 | 
					
						| MeSH Number(s) | D12.644.276.374.750.065 D12.776.395.192 D12.776.467.374.750.065 D12.776.543.550.194 D23.529.374.750.065 | 
					
						| Concept/Terms | 4-1BB Ligand4-1BB Ligand4 1BB LigandTumor Necrosis Factor Ligand Superfamily Member 9Tumor Necrosis Factor (Ligand) Superfamily, Member 94-1BBL Protein4 1BBL ProteinCD137 Ligand
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "4-1BB Ligand".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "4-1BB Ligand".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "4-1BB Ligand" by people in this website by year, and whether "4-1BB Ligand" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2020 | 1 | 0 | 1 | 
| 2024 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "4-1BB Ligand" by people in Profiles.
						
					
								- 
								Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy. Cell Rep. 2024 05 28; 43(5):114141. 
- 
								A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target. J Clin Invest. 2020 03 02; 130(3):1405-1416.